clinical trial

(redirected from Clinical study)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Clinical study: Clinical Study Report
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for clinical trial

a rigorously controlled test of a new drug or a new invasive medical device on human subjects

References in periodicals archive ?
After thorough analysis of the data, the study results were summarized in a Clinical Study Report which concluded that the drug was safe and well tolerated.
An alternative breast implant can only be made available through an IDE clinical study.
Having met the primary objective of safety and tolerability in all of the patients, and having found an apparent clinical benefit to some, we are looking forward to embarking upon a larger Phase 2 clinical study in 2001.
A prospective, multi-center study clinical study approved under an Investigational Device Exemption (IDE) from the U.
In addition to Titan's discontinuation of its Phase II clinical study in CHF, the Department of Veteran's Affairs will discontinue its Cooperative Studies Program Phase II study in CHF patients.
For more information on the DASCOR clinical study contact Jennifer Hunter, Study Coordinator, at Arizona Institute for Minimally Invasive Spine Care at 602-944-2900.
This groundbreaking double-blind clinical study was conducted with neither the patient nor the doctor knowing if a placebo ("sham") procedure was performed, or if Pillar implants were placed.
Liulin Xiong from Beijing University People's Hospital presented a clinical study reporting on 62 pancreatic cancer patients treated in China.
The study, which includes a rollover patient population from a previous clinical study of the Company's first generation immunotherapy, REMUNE(R), is designed to assess the safety and ability of various doses of IR103 to induce HIV-specific immunity.
NASDAQ: BMTI) announced today that the Company has successfully completed enrollment in its Canadian pilot clinical study with its lead orthopedic product candidate GEM OS1 Bone Graft.
Their scientific leadership contributed to the initiation of a pioneering clinical study using our proprietary electroporation delivery platform for a gene-based treatment.
The Immune Response Corporation (OTCBB:IMNR) announced today the completion of the first stage of enrollment of drug-naive HIV patients in a Phase II clinical study being conducted in Italy.
This Phase III clinical study will be a double-blind, placebo controlled study, which will assess the safety and efficacy of SP01A on viral load in HIV-positive treatment experienced patients.
Full browser ?